secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2023-08-18T23:59:59+00:00
Accession:  0001683168-23-005908
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharma receives Nasdaq delisting notice for failure to meet $2.5M equity requirement
--------------------------------------------------------------------------------

- Nasdaq notified CNS Pharma on Aug 17, 2023 of non-compliance with $2.5M stockholders' equity minimum (Rule 5550(b)(1)).
- Company also does not meet alternatives of market value of listed securities or net income from continuing operations.
- No immediate delisting; company has 45 calendar days to submit a plan. Nasdaq may grant up to 180-day extension if plan accepted.
- If plan rejected, company may appeal to Nasdaq Hearings Panel; no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316823005908/0001683168-23-005908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316823005908/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-005908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer